Literature DB >> 21811892

Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.

Elena Pentsova1, Anli Liu, Marc Rosenblum, Eileen O'Reilly, Xi Chen, Adília Hormigo.   

Abstract

Gemcitabine potential myotoxicity has been described in several cases of radiation recall and in patients treated with gemcitabine alone or in combination with other chemotherapy agents. We report two cases of gemcitabine related myositis identified at our institution, and perform a literature review of cases which meet the criteria for gemcitabine induced myositis associated to either radiation therapy or chemotherapy alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811892     DOI: 10.1007/s11060-011-0672-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Radiation myositis: the possible role of gemcitabine.

Authors:  G Ganem; P Solal-Celigny; A Joffroy; D Tassy; A Delpon; O Dupuis
Journal:  Ann Oncol       Date:  2000-12       Impact factor: 32.976

2.  [Two cases of radiation myositis probably induced by recall phenomenon].

Authors:  Gouji Miura; Tsuneo Matsumoto; Nobuyuki Tanaka; Takuya Emoto; Takeo Kawamura; Naofumi Matsunaga
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  2003-09

3.  Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel.

Authors:  Alexandros S Ardavanis; Georgios N Ioannidis; Gerassimos A Rigatos
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

4.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  Gemcitabine-induced rectus abdominus radiation recall.

Authors:  Marwan G Fakih
Journal:  JOP       Date:  2006-05-09

6.  Radiation recall reaction following gemcitabine.

Authors:  G Fogarty; D Ball; D Rischin
Journal:  Lung Cancer       Date:  2001 Aug-Sep       Impact factor: 5.705

7.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

8.  Motor neuropathy due to docetaxel and paclitaxel.

Authors:  R J Freilich; C Balmaceda; A D Seidman; M Rubin; L M DeAngelis
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 9.  Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

Authors:  Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; Lee M Krug; Martee L Hensley; Eileen M O'Reilly; Raymond J Muller; Mark G Kris
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339

Review 10.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

View more
  5 in total

1.  Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma.

Authors:  Sagar C Patel; Arnold C Paulino; Danielle Johnston; Lee Wiederhold; Richard Castillo; Rajkumar Venkatramani
Journal:  Pract Radiat Oncol       Date:  2016-06-15

Review 2.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

Review 3.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 4.  Gemcitabine-induced radiation recall myositis.

Authors:  Joshua Adam Delavan; Junzo P Chino; Emily N Vinson
Journal:  Skeletal Radiol       Date:  2014-09-06       Impact factor: 2.199

5.  Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis.

Authors:  June Young Chun; Jae Myung Lee; Dong Won Ahn; Jee Won Chai; Young A Kim; Kichul Shin
Journal:  Korean J Intern Med       Date:  2016-02-26       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.